LDFWART
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LDFWART, covering 2016-08-10 to 2016-08-10. Get the full timeline:
Most recent: Clinical Trial Update: LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma [Phase 1]